Our physicians and scientists are working on a number of initiatives, including collecting blood and bone marrow from patients to better understand the causes of bone marrow failure syndromes and MDS; exploring possible genetic factors that guide medical care; collecting blood and bone marrow to identify specific proteins that are faulty and how these defects relate to clinical complications and outcomes; and clinical trials to improve stem cell transplants for disorders such
as dyskeratosis congenita.
Dysfunction in telomere maintenance pathways plays an integral role in aging, cancer, and certain rare diseases such
as dyskeratosis congenita (DC).
Not exact matches
Genetic and molecular processes underlying telomere diseases such
as cancer and
dyskeratosis congenita
Another is
dyskeratosis congenita, a rare bone marrow disorder accompanied by much more serious effects such
as early aging and predisposition to cancer.